Summit Therapeutics Granted Key Patent by European Patent Office for Utrophin Modulator SMT C1100 in the Treatment of DMD

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.